Antitrust Issues in Life Sciences Industries under the New Administration

• Strategic Transactions: Impact of Antitrust on Options, Licenses, Partnering, M&A (HSR Process, Timeline, and Impact on Structuring)
• Building and Extending the Franchise: Antitrust Issues in Sales and Life Cycle Management Strategies (Bundled Discounts, Pricing, Product Switching, etc.)
• Attacking and Defending the Franchise: Antitrust Issues in IP Litigation and Settlement

WHO SHOULD ATTEND:
Senior management of life sciences companies, as well as legal, finance, and business development professionals at all levels; life sciences investors.

MORRISON & FOERSTER SPEAKERS:
Sean Gates
Jeffrey Jaeckel
David L. Meyer

Morrison & Foerster LLP (Provider #2183) certifies that this activity has been approved for MCLE credit by the State of California in the amount of 1 hour.